Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis

被引:5
|
作者
Suen, Christopher F. D. Li Wai [1 ,2 ]
Seah, Dean [1 ]
Choy, Matthew C. [1 ,2 ]
De Cruz, Peter [1 ,2 ,3 ]
机构
[1] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Vic, Australia
[3] Austin Hlth, Dept Gastroenterol, 145 Studley Rd, Heidelberg, Vic 3084, Australia
关键词
acute severe ulcerative colitis; infliximab; cyclosporin; colectomy; prognosis; LONG-TERM OUTCOMES; INTRAVENOUS CYCLOSPORINE; HOSPITALIZED-PATIENTS; INFLIXIMAB INDUCTION; PREDICTIVE FACTORS; FECAL CALPROTECTIN; ENDOSCOPIC SCORE; COLECTOMY RATES; FOLLOW-UP; EFFICACY;
D O I
10.1093/ibd/izad183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Acute severe ulcerative colitis (ASUC) is a medical emergency for which colectomy is required in patients who do not respond to rescue therapy. While previous studies have predominantly focused on predicting outcome to first-line corticosteroid therapy, there is a need to understand the factors associated with response to rescue therapies in order to improve clinical outcomes. We reviewed the evidence regarding factors associated with response to rescue therapy in adults with ASUC and identified future directions for research.Methods A systematic search of the literature was conducted, and 2 reviewers independently assessed studies for inclusion.Results Of 3509 records screened, 101 completed studies were eligible for inclusion. We identified 42 clinical, hematological, biochemical, endoscopic, or pharmacological factors associated with response to rescue therapy. Older age (& GE;50 years), thiopurine experience, and cytomegalovirus or Clostridioides difficile infection were associated with a higher risk of nonresponse to rescue therapy. Biochemical factors associated with poorer response included an elevated C-reactive protein (CRP) & GE;30mg/L on admission, hypoalbuminemia and an elevated ratio of CRP to albumin. Severe endoscopic findings, including a Mayo endoscopic score of 3 or Ulcerative Colitis Endoscopic Index of Severity & GE;5, portended poorer outcomes. The role of fecal calprotectin and therapeutic value of measuring infliximab drug levels in ASUC remain to be defined.Conclusions Response to rescue therapy can be predicted by several specific factors, which would aid clinical decision-making. Existing and emerging factors should be integrated within predictive and prognostic models to help improve clinical outcomes. In this review, we summarize the clinical, hematological, biochemical, radiological, endoscopic, and drug-related factors that predict or are associated with response to rescue therapy in patients with acute severe ulcerative colitis. We also provide a clinical algorithm for clinicians. Graphical Abstract
引用
收藏
页码:1389 / 1405
页数:17
相关论文
共 50 条
  • [11] Use of Infliximab as rescue therapy in acute severe Ulcerative Colitis with recent norovirus infection
    O'Connor, J. P. A.
    O'Morain, C. A.
    Neary, P.
    Breslin, N. P.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03): : 204 - 206
  • [12] Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature
    Ali, Nargess Mahmoud
    Shehab, Mohammad Abdullah
    AMERICAN JOURNAL OF CASE REPORTS, 2023, 24
  • [13] Access to out-of-hours rescue therapy for acute severe ulcerative colitis in Australia
    Laube, R.
    Ali, M. S.
    Leong, R. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 98 - 99
  • [14] High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis
    Dai, Cong
    Jiang, Min
    Sun, Ming-jun
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (05) : 1386 - 1387
  • [15] An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis
    Divya Ashat
    Animesh Jain
    Kimberly N. Weaver
    Millie D. Long
    Hans H. Herfarth
    Edward L. Barnes
    Digestive Diseases and Sciences, 2022, 67 : 5439 - 5443
  • [16] Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis
    Syal, Gaurav
    Robbins, Lori
    Kashani, Amir
    Bonthala, Nirupama
    Feldman, Edward
    Fleshner, Phillip
    Vasiliauskas, Eric
    McGovern, Dermot
    Ha, Christina
    Targan, Stephan
    Melmed, Gil Y.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 199 - 205
  • [17] A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
    Lees, C. W.
    Heys, D.
    Ho, G. T.
    Noble, C. L.
    Shand, A. G.
    Mowat, C.
    Boulton-Jones, R.
    Williams, A.
    Church, N.
    Satsangi, J.
    Arnott, I. D. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 411 - 419
  • [18] An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis
    Ashat, Divya
    Jain, Animesh
    Weaver, Kimberly N.
    Long, Millie D.
    Herfarth, Hans H.
    Barnes, Edward L.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (12) : 5439 - 5443
  • [19] Infliximab is effective as rescue therapy for acute severe ulcerative colitis: The initial Edinburgh experience
    Lees, CW
    Shand, AG
    Penman, ID
    Arnott, ID
    Satsangi, J
    GUT, 2006, 55 : A79 - A79
  • [20] Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision?
    Derikx, L. A. A. P.
    Hoentjen, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1296 - 1297